INTRODUCTION
Neisseria meningitidis is an important cause of meningitis in children and young adults worldwide [1, 2] . However, although asymptomatic carriage is frequent [3] , the development of meningococcal disease is relatively rare. In the UK it has been estimated that most individuals experience up to 10 meningococcal carriage episodes during their lifetime [4] , while disease develops in only 2-5 individuals per 100,000 per year. The disparity between frequency of carriage and disease may be partly accounted for by the low virulence of many carriage strains but also suggests a role for naturally acquired protective immunity [2, 5, 6] .
Naturally developed immunity is believed to occur through multiple colonization events at the mucosal surface by N. meningitidis, related organisms such as Neisseria lactamica and other antigenically cross reacting flora [7] . There is considerable evidence that either naturally acquired or vaccine-induced circulating complement fixing IgG antibody, high in bactericidal activity, protects against invasive disease [1, 6, 8, 9] . We have previously demonstrated T-cell mediated immunological memory to N. meningitidis at the mucosal level which has a predominately proinflammatory phenotype. We have shown that the magnitude of these responses is highly regulated and increases with age [10, 11] . IgA is the major antibody at mucosal surfaces in the upper respiratory tract and mucosal clearance through the elaboration of secretory IgA is considered to be important in limiting meningococcal colonization and preventing early invasion. We have previously reported a link between salivary antimeningococcal IgA levels and the incidence of meningococcal infection in the population [2] .
However, the target meningococcal antigens for this IgA and the mechanisms of this immunity are uncertain.
IgA consists of two subclasses, IgA1 and IgA2, differing almost exclusively by a 13 amino acid sequence present in the hinge region of IgA1 [12] , the most common isotype at most mucosal surfaces [13] . The hinge region is the site of cleavage for IgA1 proteases expressed by a number of pathogens including N. meningitidis and Streptococcus pneumonia [14, 15] .
Serum IgA is mainly monomeric whereas mucosal IgA is mostly dimeric, synthesized by B cells located in the mucosal associated lymphoid tissue (MALT) [16] . During transcytosis of
IgA through epithelial cells, the extracellular domain of the receptor for dimeric IgA, the polymeric Ig receptor (PIgR), is cleaved from the cells (secretory component) and remains complexed with IgA (secretory IgA).
We created a panel of humanized chimeric antibodies with identical mouse V regions, and different human constant (C) regions against a single PorA epitope (P1.16 in surface loop four) [17] . Meningococcal PorA is a membrane spanning protein with eight well conserved surface exposed loops [18] with the exception of two hyper variable regions (VR1 and VR2) [19] . While chimeric IgG1 and IgG3 were both good activators of complement mediated lysis, neither IgA1 nor IgA2 activated complement but blocked IgG mediated killing in a concentration dependent manner. In the present study we have shown strong immunoreactivity by human salivary IgA against the meningococcal outer membrane porin, PorA. We demonstrate that anti-PorA IgA1 antibodies increase meningococcal association with Chang epithelial cells and suggest that this interaction occurs through a specific IgA receptor.
RESULTS

Anti-PorA IgA is highly represented in human saliva
We have previously reported the presence of IgA to a range of meningococcal outer membrane proteins saliva samples obtained from adults and children [2] . Subsequent experiments were carried out to determine the targets of IgA antibodies. Densitometry analysis of OMV Western blots (Fig 1a) , with proteins identified by band size, demonstrated strong immunoreactivity of salivary antibodies against PorA and to a lesser extent PorB (Fig 1b) . This was despite very similar levels of PorA and PorB in OMVs [20] . Antibodies to RmpM (putative peptidoglycan binding protein [21] ), Opa, Opc and putative OMP P1 were also detected in some subjects (Fig 1a and data not shown).
Monomeric IgA1 (mIgA1) but not IgG1 increases meningococcal association with
Chang epithelial cells
To determine the potential functional effects of anti-PorA antibody on meningococcal interactions with the mucosal barrier, we initially co-cultured with H44/76 (P1. [22] . The Chang cell line was selected because it expresses low levels of CEACAMs which are potent mediators of Opa-dependent epithelial adherence and invasion [23] [24] [25] . Time course experiments using an unencapsulated H44/76
derivative revealed an increase in meningococcal-epithelial association over three hours which was further enhanced by specific mIgA1 (Fig 2a) (9.881 x 10 4 cfu / well ± sem 1.9 x 10 4 vs 16.97 x 10 4 cfu / well ± sem 0.7813 x 10 4 with specific mIgA1, P=0.0435). This antibody-mediated increase in association was not seen with humanised IgG specific for the same epitope of the PorA loop region (Fig 2b) (sem=0.5025±4.334). Association assays using F(ab) 2 fragments showed that the effects of mIgA1 on meningococcal association with Chang cells are Fc fragment dependent (Fig 2b) .
It has previously been shown that capsulation reduces adherence of meningococci to Chang epithelial cells [24] [25] [26] . In this study the effect of monomeric IgA1 (mIgA1) on the capsulated parent N. meningitidis H44/76 strain was examined but no increase in epithelial association was observed.
Modulation of meningococcal association with other epithelial cells by mIgA1
To (Fig 4c&d) .
In order to determine whether the state of the cell cycle influences binding of IgA to Chang cells, thereby providing a possible explanation for the observation that IgA only binds to 20-45% of the total Chang cell population, previous experiments were repeated following treatment with the cell cycle inhibitor, aphidicolin [27] . This treatment approximately doubled the amount of serum derived IgA1 binding to Chang cells (Fig 4e&f) .
Role of known IgA receptors in IgA binding to Chang cells
Several IgA receptors have been described on epithelial cells which bind mIgA, pIgA or both [28] . To assess which receptor might be involved, binding competition experiments were conducted. No interference between serum and colostrum derived IgA were seen, even at high concentrations of competing IgA (Fig 5a) . In order to investigate the possibility that pIgA may bind to Chang cells via the J chain, competition experiments were conducted with IgM which is a pentameric immunoglobulin, also possessing a J chain. These demonstrated that
IgM was unable to inhibit binding of colostrum derived IgA to Chang cells (Fig 5b) .
The asialoproteoglycan receptor (ASPGR) binds to terminal galactose and N-acetyl-Dgalactosamine (NAG) residues found on IgA [29] . It is therefore possible to inhibit binding of IgA by adding its natural ligand, NAG. However in this study, NAG did not inhibit IgA binding to Chang cells, even at concentrations of 1mg/ml (Fig 5c) . To explore the possibility that the FcαR or the polymeric IgA receptor (pIgR) mediate the IgA binding observed RT-PCR was carried out. mRNA for both receptors was shown to be absent in Chang cells (Fig 6) , which implies that neither receptor is expressed.
DISCUSSION
IgA is present in abundant quantities in mucosal secretions [30] and is widely believed to prevent colonisation and invasion by upper respiratory tract bacteria such as N. meningitidis.
However, little is known regarding its mechanisms of action. IgA activates the classical complement pathway poorly [17, 31] and has traditionally been viewed as anti-inflammatory, blocking the mucosal effects of microbial antigens through three major mechanisms. Firstly, the prevention of attachment and invasion by micro-organisms by surrounding them with a hydrophilic shell, interference with motility due to interactions with flagella [32] , or neutralising bacterial products [33] . Secondly, binding antigens and transporting them through the epithelium, thus eliminating excess antigens from the mucosa. Thirdly, interception of antigens during viral transcytosis and intracellular neutralisation by interference with viral assembly or synthesis [34] . In relation to the meningococcus, research in this area has been hampered by the lack of good laboratory models and the paucity of related reagents. In this study, we have used chimeric antibodies specific for N. meningitidis PorA to investigate their role at the mucosal epithelium. We show that in Chang epithelial cells which express low levels of CEACAMs (an important receptor for Opa-mediated meningococcal adherence and invasion) [25] , anti-PorA IgA but not IgG leads to an increase in meningococcal association but not invasion. In contrast, with A549 (alveolar) and Detroit (pharyngeal) epithelial cells which express higher levels of CEACAMs, anti-PorA IgA does not increase meningococcalepithelial cell association. PorA is not known to mediate direct interactions with host cells but the finding of mucosal IgA specific for PorA together with evidence that anti-PorA IgA enhances meningococcal interaction with some epithelia implicates this IgA in either immune clearance or a novel colonisation mechanism.
N. meningitidis shows considerable tropism for upper respiratory tract epithelium [35, 36] .
Many carried strains are unencapsulated [37] and our data suggests that compared to encapsulated meningococci, these are most susceptible to anti-PorA IgA1-enhanced epithelial cell association, presumably through greater exposure of the PorA antigen. However, we found no evidence that meningococci upregulated IgA binding either directly or indirectly (unpublished observation) as has been seen with other receptor pathways. The inter-cell line differences described here may reflect the highly variable expression of different IgA surface receptors or differential usage of the same receptor. However, we suggest that CEACAM-Opa interactions which are responsible for significantly greater adhesion to A549 compared with
Chang cell lines used in current studies [23] may have masked the influence of anti-PorA mIgA. Opa proteins are subject to phase variation [38] and CEACAMs may vary in receptor density [25] . Follow-on studies are therefore investigating whether primary epithelial cells and several largely uncharacterised receptors [41] [42] [43] [44] have also been shown to bind IgA. We been shown that its cleavage leads to the release of a proportion of bound Fab fragments [47] which would explain why we were unable to demonstrate an attenuation of meningococcal association when using a strain in which the IgA protease has been knocked out (unpublished observation).
Conclusions
In conclusion, naturally-acquired anti-PorA IgA is prominent in human saliva. Our data have
shown that anti-PorA IgA increases meningococcal-epithelial adhesion with Chang cells and suggest that anti-meningococcal IgA may regulate commensal colonisation and prevent invasion via specific IgA epithelial receptor(s). However, our findings do not preclude the possibility that meningococci may subvert the immune system to use IgA and its receptors to aid colonisation and invasion. The next step is clearly the use of primary nasopharyngeal epithelial cells in association assays in order to elucidate the biological significance of the data presented here, and the precise mechanism in an ex-vivo scenario. We have previously
shown that systemic vaccination with MenB vaccines does not increase meningococcalspecific salivary IgA [48] . Nonetheless, the precise role of mucosal IgA against meningococcal surface antigens needs to be determined in order to inform future vaccine strategies against N. meningitidis and other mucosal pathogens.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Serogroup B meningococcal strains used in this investigation were MC58 (B15:P1.7,16;L3,7,9) [49] , TR4 (B15:P7-2,4;L3,7,9), H44/76 (B15:P1.7,16;L3,7,9) [50] and a spontaneous unencapsulated H44/76 mutant. All strains were grown from frozen glycerol stocks and used after overnight growth on BHI agar supplemented with 10% horse blood at 37°C, 5% CO 2 .
Cell Lines and Culture Conditions
Human epithelial cell lines were grown in the following media: Chang conjunctival epithelial cells, Medium 199; A549 lung pneumocyte cells, F-12 HAM nutrient medium and Detroit 562 pharyngeal cells, minimum essential Eagle's medium, 1 mM sodium pyruvate, 1% nonessential amino acids. All media were supplemented with 10% FCS, 4mM L-Glutamine and 100µg/ml penicillin/streptomycin and grown at 37°C, 5% CO 2. Media components were from Invitrogen (CA, USA) unless otherwise stated.
SDS-PAGE of outer membrane vesicles (OMVs) and Western Blotting
For SDS-PAGE and Western blotting [51] , OMVs (kind gifts from RIVM (The Netherlands)) [10] in NuPAGE LDS sample buffer, were boiled briefly and loaded onto a NuPAGE 10%
Bis-Tris pre-cast gel (Invitrogen), and run at 180V for 1 hour. Transfer was carried out after soaking in transfer buffer (2.91g Trizma base, 1.47g glycine, 0.188g SDS, 100ml methanol in 400mls distilled water) using a Trans-blot semi-dry transfer cell (Bio-Rad) for 15 minutes, 15V. The gel was stained using Gel Code blue stain reagent (Pierce, Rockford, USA). 
Chimeric Antibodies
BHK cell lines producing chimeric IgG and IgA-anti PorA P1.16 [17] were grown in 
Generation of F(ab) 2 fragments
Purified chimeric IgA1 was subjected to digestion by pepsin (50mg/ml pepsin (Sigma) in 20mM sodium acetate, pH5.0) to yield F(ab) 2 fragments. IgA1 was digested for 60 minutes,
RT. The reaction was stopped by addition of 1.5M Tris-HCl, pH 8.8 to create a neutral pH.
F(ab) 2 fragments were separated from the resulting mixture using a jacalin column as described above.
Cell Association Assays
Bacterial association and invasion was measured by viable count assays as previously described [36] . Briefly, meningococci were pre-incubated for ten minutes, RT, with the relevant antibody then incubated with epithelial cell monolayers (approximately 500 meningococci per cell) for three hours, 37ºC. Monolayers were washed and permeabilised using 1% saponin and released cell-associated bacteria plated onto brain-heart infusion agar supplemented with 5% heated horse serum (HBHI) for overnight incubation. Colonies were counted and used to estimate the number of cell-associated bacteria from the original inoculum.
Cell free control wells present in each assay ensure that differences in colony numbers are due to cell binding not association with plastic.
RNA extraction and RT-PCR for IgA receptors
RNA was extracted from confluent cell monolayers using RNAqueous-4PCR (Ambion, Texas, USA), as per manufacturer's instructions. Approximate RNA concentrations were calculated by absorbance at 260nm and 280nm. RT-PCR was performed using the Access RT-PCR system (Promega). First strand cDNA was synthesized using AMV reverse transcriptase and oligo (dT) at 48°C for 45 minutes and 42°C for 60 minutes for pIgR and to The Sequencing Service, University of Dundee, Scotland. Probable sequence products were then identified using Genomes Fasta (http://www.ebi.ac.uk/fasta33/genomes.html).
Antibody Biotinylation
Human serum-derived and colostrum-derived IgA (Sigma) were biotinylated for use in flow cytometry using an EZ-Link Sulfo-NHS-Biotinylation kit (Pierce) as per manufacturer's instructions. The level of biotin incorporation was measured by a HABA assay and levels of 11.81 and 3.86 moles biotin per mole IgA were achieved for IgA from serum and colostrum respectively.
Flow Cytometry
Chang cell monolayers were grown to confluency overnight in 24 well plates (Invitrogen) and monolayers were disrupted with Pucks saline and re-suspended in PBS, 10% FCS [53] . 
Cell Cycle Synchronisation
Aphidicolin, a reversible DNA polymerase inhibitor, was used to block cells at the G1 to S phase transition of the cell cycle, employing a method described by Kues et al. [54] . Chang cells were grown in 24 well plates (Invitrogen) until 60-80% confluency (logarithmic growth phase) was reached. Growth medium was then replaced with medium containing only 0.2% FCS, and after a further 48 hours replaced with medium containing 10% FCS and 6µM
Aphidicolin. Cells were then cultured for 14 hours prior to flow cytometry.
Statistical Analysis
All data analyses were carried out using Prism version 3.0 (GraphPad Software). For association data, the bar charts represent the mean of three wells while the vertical bars show the standard error of the mean (SEM). Different conditions were compared with the control wells using the paired t-test. carried out using the Access RT-PCR system (Promega). Positive control for FcαR is PMA stimulated U937 cells [56] , and for pIgR is Detroit cells with A549 cells as pIgR negative control [57] .
